Conference Calendar

Keystone Symposium on Molecular and Cellular Biology: Neuroinflammation in Diseases of the Central Nervous System

Taos, New Mexico
View Conference Website

Neuroinflammation, the response of the central nervous system (CNS) to disturbed homeostasis, typifies all neurological diseases, from primary-inflammatory; to developmental; traumatic; ischemic; neoplastic; and neurodegenerative. Disease-associated neuroinflammatory responses aren’t evolutionarily-selected to minimize or repair tissue injury, and may be helpful, harmful or neutral. This research is promising because neuropathological, epidemiologic, genetic, animal-model and biomarker studies indicate pertinence of inflammation for neurological disease and because current and re-purposed therapeutics might beneficially modify neuroinflammation. The research is urgent because therapeutic options for these diseases are presently lacking. The meeting will: 1) Address the developmental roles of neuroinflammatory cells including microglia and blood-brain barrier (BBB) neurovascular elements; 2) Clarify how neuroinflammatory reactions mediate host defense against neuroinvasive microbial pathogens and also how the response to systemic inflammation affects the neuroinflammatory elements.; 3) Specify critically-important neuroinflammatory cells (microglia; astrocytes; NG2+ glia; BBB); receptors (Toll-like receptors; inflammasomes; cytokine receptors); signaling pathways and effector mechanisms; and 4) Identify the most salient targets of neuroinflammation (neurons; neural progenitor and stem cells; oligodendroglia) and mechanisms of injury. Neuroscientists and immunologists work on individual elements of these questions. This meeting will develop a common body of knowledge and opportunities for productive interaction, to begin maturing the field. This meeting will be the first Keystone Symposia meeting on neuroinflammation. Single-disease-focused meetings have occurred and suggest opportunities of neuroscientist/immunologist interactions. The present meeting will be the first to bring together the many communities of disease-focused neuroscientists and immunologists with an interest in the CNS. This nascent field needs a committed, interactive community and this Keystone Symposia conference promises to play a key role.